.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Digital health tools are transforming patient care by providing data-driven insights into lifestyle habits. Currently, the private equity owner of MyFitnessPal is exploring a sale that could value the app at over $1 billion. Francisco Partners is reportedly working with JPMorgan to manage the process. This news highlights the massive financial growth within the health technology sector.
The adoption of nutrition and fitness applications has surged globally. MyFitnessPal, founded in 2005, now boasts over 280 million members. It helps users track calories, vitamins, and exercise. Consequently, healthcare providers increasingly utilize these data points to support clinical outcomes in chronic disease management. Patients benefit from the premium features, such as on-demand video workouts and personalized meal plans.
Furthermore, the shift towards digital integration allows for better patient engagement. Platforms like MyFitnessPal, Strava, and Oura rings provide real-time insights that were previously unavailable. Because of this, the market for digital health tools continues to attract significant investment and valuation. Additionally, the potential sale signifies a broader trend of consolidation in digital wellness. This synergy creates a robust ecosystem for monitoring patient health outside of clinical settings.
Q1: What is the current valuation of MyFitnessPal?
Sources indicate that the sale could value the application at over $1 billion.
Q2: Who currently owns the MyFitnessPal application?
Francisco Partners, a technology-focused investment firm, currently owns the platform after acquiring it from Under Armour in 2020.
Q3: How many users does MyFitnessPal have globally?
The company reported having over 280 million members across 120 different countries as of last year.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Private equity firm Francisco Partners explores a $1 billion sale of MyFitnessPal, highlighting the booming global demand for digital health tools....
5 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
